NOT-CA-17-022: Notice of Expiration of PAR-14-285 "Innovative Research in Cancer Nanotechnology (IRCN) (U01)"

Notice of Expiration of PAR-14-285 "Innovative Research in Cancer Nanotechnology (IRCN) (U01)"

Notice Number: NOT-CA-17-022

Key Dates
Release Date: January 23, 2017

Related Announcements
PAR-14-285

Issued by
National Cancer Institute (NCI)

Purpose

This Notice is to inform the research community of the expiration of PAR-14-285 "Innovative Research in Cancer Nanotechnology (IRCN) (U01)", effective immediately.

Inquiries

Please direct all inquiries to:

Piotr Grodzinski
National Cancer Institute (NCI)
Telephone: 301-451-8983
Email: [email protected]

Stephanie Morris
National Cancer Institute (NCI)
Telephone: 301-451-8983
Email: [email protected]